Catheter Precision, Inc. Selling, General and Administrative Expense
Catheter Precision, Inc. (VTAK) reported Selling, General and Administrative Expense of $3.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- Catheter Precision, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $3.91M, a 35.75% increase year-over-year.
- Catheter Precision, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.56M, a 26.57% decline year-over-year.
- Catheter Precision, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $2.76M, a 11.04% decline year-over-year.
- Catheter Precision, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.95M, a 2.46% increase year-over-year.
- Catheter Precision, Inc. selling, general and administrative expense for fiscal 2025 was $12.07M, a 6.40% increase from fiscal 2024.
- Catheter Precision, Inc. selling, general and administrative expense for fiscal 2024 was $11.35M, a 33.72% decline from fiscal 2023.
- Catheter Precision, Inc. selling, general and administrative expense for fiscal 2023 was $17.12M, a 5.37% increase from fiscal 2022.
- Catheter Precision, Inc. selling, general and administrative expense for fiscal 2022 was $16.25M, a 5.01% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.91M 10-Q · filed 2026-08-14 | $6.47M 10-Q · filed 2026-08-14 | $9.23M derived: sum of 3 quarters · filed 2026-08-14 | $12.18M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $2.56M 10-Q · filed 2026-05-18 | $5.32M derived: sum of 2 quarters · filed 2026-05-18 | $8.27M derived: sum of 3 quarters · filed 2026-05-18 | $11.15M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.71M derived: sum of 2 quarters · filed 2026-03-31 | $8.59M derived: sum of 3 quarters · filed 2026-08-14 | $12.07M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $2.95M 10-Q · filed 2025-11-13 | $5.83M derived: sum of 2 quarters · filed 2026-08-14 | $9.32M 10-Q · filed 2025-11-13 | $12.42M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $2.88M 10-Q · filed 2026-08-14 | $6.37M 10-Q · filed 2026-08-14 | $9.46M derived: sum of 3 quarters · filed 2026-08-14 | $12.35M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $3.48M 10-Q · filed 2026-05-18 | $6.58M derived: sum of 2 quarters · filed 2026-05-18 | $9.46M derived: sum of 3 quarters · filed 2026-05-18 | $12.18M derived: sum of 4 quarters · filed 2026-05-18 | ||||
| 2024-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.98M derived: sum of 2 quarters · filed 2026-03-31 | $8.69M derived: sum of 3 quarters · filed 2026-03-31 | $11.35M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $2.88M 10-Q · filed 2025-11-13 | $5.59M derived: sum of 2 quarters · filed 2025-11-13 | $8.25M 10-Q · filed 2025-11-13 | $10.98M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $2.71M 10-Q · filed 2025-08-11 | $5.37M 10-Q · filed 2025-08-11 | $8.10M derived: sum of 3 quarters · filed 2025-08-11 | $10.84M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $2.66M 10-Q · filed 2025-05-14 | $5.38M derived: sum of 2 quarters · filed 2025-05-14 | $8.13M derived: sum of 3 quarters · filed 2025-05-14 | $9.54M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.47M derived: sum of 2 quarters · filed 2025-03-31 | $6.89M derived: sum of 3 quarters · filed 2025-03-31 | $17.12M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $2.75M 10-Q · filed 2024-11-14 | $4.16M derived: sum of 2 quarters · filed 2024-11-14 | $14.39M 10-Q · filed 2024-11-14 | $22.35M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.42M 10-Q · filed 2024-08-14 | $11.65M 10-Q · filed 2024-08-14 | $19.61M derived: sum of 3 quarters · filed 2024-08-14 | $23.12M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $10.23M 10-Q · filed 2024-05-06 | $18.19M derived: sum of 2 quarters · filed 2024-05-06 | $21.70M derived: sum of 3 quarters · filed 2024-05-06 | $24.18M derived: sum of 4 quarters · filed 2024-05-06 | ||||
| 2022-12-31 | $7.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $11.47M derived: sum of 2 quarters · filed 2024-04-01 | $13.95M derived: sum of 3 quarters · filed 2024-04-01 | $16.25M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $3.51M 10-Q · filed 2023-12-21 | $5.99M derived: sum of 2 quarters · filed 2023-12-21 | $8.29M 10-Q · filed 2023-12-21 | $12.48M derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2022-06-30 | $2.48M 10-Q · filed 2023-12-15 | $4.78M 10-Q · filed 2023-12-15 | $8.97M derived: sum of 3 quarters · filed 2023-12-15 | $13.18M derived: sum of 4 quarters · filed 2023-12-15 | ||||
| 2022-03-31 | $2.30M 10-Q · filed 2023-06-02 | $6.49M derived: sum of 2 quarters · filed 2023-06-02 | $10.70M derived: sum of 3 quarters · filed 2023-06-02 | $14.10M derived: sum of 4 quarters · filed 2023-06-02 | ||||
| 2021-12-31 | $4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $8.40M derived: sum of 2 quarters · filed 2023-03-28 | $11.80M derived: sum of 3 quarters · filed 2023-03-28 | $15.47M 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | $4.21M 10-Q · filed 2022-11-14 | $7.61M derived: sum of 2 quarters · filed 2022-11-14 | $11.29M 10-Q · filed 2022-11-14 | $17.66M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $3.40M 10-Q · filed 2022-08-16 | $3.74M 10-Q · filed 2021-08-11 | $7.08M 10-Q · filed 2022-08-16 | $7.86M 10-Q · filed 2021-08-11 | $13.45M derived: sum of 3 quarters · filed 2022-08-16 | $18.15M derived: sum of 4 quarters · filed 2022-08-16 | ||
| 2021-03-31 | $3.68M 10-Q · filed 2022-05-16 | $4.11M 10-Q · filed 2021-05-12 | $10.06M derived: sum of 2 quarters · filed 2022-05-16 | $14.75M derived: sum of 3 quarters · filed 2022-05-16 | $22.65M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $11.07M derived: sum of 2 quarters · filed 2022-03-24 | $18.97M derived: sum of 3 quarters · filed 2022-03-24 | $24.53M 10-K · filed 2022-03-24 | $25.97M 10-K · filed 2021-03-17 | |||
| 2020-09-30 | $4.70M 10-Q · filed 2021-11-15 | $4.93M 10-Q · filed 2020-11-16 | $12.59M derived: sum of 2 quarters · filed 2021-11-15 | $18.15M 10-Q · filed 2021-11-15 | $19.11M 10-Q · filed 2020-11-16 | $27.52M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $7.90M 10-Q · filed 2021-08-11 | $14.18M 10-Q · filed 2021-08-11 | $22.82M derived: sum of 3 quarters · filed 2021-08-11 | $38.71M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $6.29M 10-Q · filed 2021-05-12 | $14.93M derived: sum of 2 quarters · filed 2021-05-12 | $30.82M derived: sum of 3 quarters · filed 2021-05-12 | $44.60M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $8.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $24.53M derived: sum of 2 quarters · filed 2021-03-17 | $38.32M derived: sum of 3 quarters · filed 2021-03-17 | $51.55M 10-K · filed 2021-03-17 | ||||
| 2019-09-30 | $15.89M 10-Q · filed 2020-11-16 | $29.68M derived: sum of 2 quarters · filed 2020-11-16 | $42.91M 10-Q · filed 2020-11-16 | $57.72M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $13.79M 10-Q · filed 2020-08-11 | $27.02M 10-Q · filed 2020-08-11 | $41.83M derived: sum of 3 quarters · filed 2020-08-11 | $47.20M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $13.23M 10-Q · filed 2020-05-14 | $28.04M derived: sum of 2 quarters · filed 2020-05-14 | $33.41M derived: sum of 3 quarters · filed 2020-05-14 | $41.02M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $14.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $20.18M derived: sum of 2 quarters · filed 2020-03-11 | $27.80M derived: sum of 3 quarters · filed 2020-03-11 | $30.43M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $5.37M 10-Q · filed 2019-11-29 | $12.98M derived: sum of 2 quarters · filed 2019-11-29 | $15.62M 10-Q · filed 2019-11-29 | $18.64M derived: sum of 4 quarters · filed 2019-11-29 | ||||
| 2018-06-30 | $7.62M 10-Q · filed 2019-11-29 | $10.25M 10-Q · filed 2019-11-29 | $13.27M derived: sum of 3 quarters · filed 2019-11-29 | $15.17M derived: sum of 4 quarters · filed 2019-11-29 | ||||
| 2018-03-31 | $2.64M 10-Q · filed 2019-05-14 | $5.65M derived: sum of 2 quarters · filed 2019-05-14 | $7.56M derived: sum of 3 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $4.92M derived: sum of 2 quarters · filed 2019-03-15 | $14.95M 10-K · filed 2019-03-15 | |||||
| 2017-09-30 | $1.90M 10-Q · filed 2018-11-14 | $11.93M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |